Indonesian Asthma Gymnastic added to pulmonary rehabilitation for adults with asthma
Official title: EFFICACY OF INDONESIAN ASTHMATIC GYMNASTIC AS COMBINE PULMONARY REHABILITATION IN ASTHMATIC PATIENT BASED ON ASTHMA CLASSIFICATION
Run by RSUP Persahabatan · NCT07480616 · Data updated 2026-11-12
This project will test whether adding Indonesian Asthma Gymnastic to usual care helps adults with stable asthma improve walking distance, symptom control, peak flow, and lung function.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 65 Years |
| Sex | All |
| Enrollment | 35 (estimated) |
| Sponsor | RSUP Persahabatan Academic / other |
| Locations | 1 site (Jakarta) |
| Status | Recruiting |
| Started | October 6, 2025 |
| Main results expected | July 2026 |
| Study ends | September 2026 |
| Registry record updated | March 18, 2026 |
| Trial ID | NCT07480616 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults aged 18–65 with stable asthma who are already on routine asthma treatment and willing to participate in supervised exercise sessions.
✕Probably not a fit
Patients with a current asthma exacerbation, other chronic lung diseases, or neuromuscular conditions affecting breathing are unlikely to benefit or be eligible for this program.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This is an interventional program that adds a structured Indonesian Asthma Gymnastic exercise routine to participants' ongoing standard asthma treatment, including medication and lifestyle education. Adults aged 18–65 with stable asthma will perform the exercise program while outcomes are measured before and after the intervention. Primary outcome measures include the 6-minute walk test, Asthma Control Test, peak expiratory flow rate, and lung function (spirometry). The program is conducted at a single center (RSUP Persahabatan) and excludes patients with recent exacerbations, other lung diseases, or neuromuscular disorders affecting respiration.
Why it matters
Potential benefit: If successful, this program could increase exercise tolerance, improve symptom control, and modestly improve lung function for adults with stable asthma.
How similar studies have gone: Related pulmonary rehabilitation and breathing-exercise programs have shown benefits for asthma control and exercise capacity, but this specific Indonesian Asthma Gymnastic approach appears relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Diagnosed with stable asthma * Age 18-65 years old * Competent and willing to be included in the trial Exclusion Criteria: * Asthma exacerbation * Had other lung disease * Had neuromuscular disease affecting respiratory system
Where it's running
-
RSUP Persahabatan
Jakarta, Indonesia Recruiting
Study contacts
- Study coordinator: Veronika R Kurniawati
- Email: veronikarennykurniawati@gmail.com
- Phone: +62 87857355235
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
IOS-based platform to screen, diagnose, and manage COPD and asthma
This study tests an Impulse Oscillometry system to screen for and diagnose COPD and asthma and to help predict flare-ups over about a year, involving adults in China.
-
REACH: Resources and Education to Help Kids with Asthma in School
A service model called REACH will try to improve school-based asthma care by coordinating care between healthcare, school, and home for children with asthma.
-
Beclometasone Dipropionate and Formoterol inhalation combo vs FOSTER in adults with asthma
This Phase 3 trial tests whether a beclometasone formoterol inhalation combo works as well or better than FOSTER for adults with asthma.
-
Test of SKB575 in adults with asthma
This study tests whether SKB575 helps people with asthma compared to a placebo.
-
KT-621 long-term safety and efficacy in asthma patients previously in KT-621 study
This phase 2b study tests KT-621 in people with asthma who finished a prior KT-621 study to see if long-term treatment is safe and helpful.
-
Dog-allergy immunotherapy with Alutard SQ Dog in Swedish practice
This study tests whether Alutard SQ Dog immunotherapy helps adults with moderate-to-severe dog allergy when used in real-world Swedish care.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.